C Garrido-Colino^1,6,7,8 A H Haro Diaz², E J Bardón-Cancho^1,6,7, M Navarro Gomez^3,6,7, C Beléndez^1,6,7,8, J Huerta Aragonés^1,6,7, M Garcia-Morin^1,6,7, C M Fernández-Llamazares^5,6, A Burillo^4,6, E Cela^1,6,7,8

¹Pediatric Hematology and Oncology Unit, Department of Pediatrics, Hospital General Universitario Gregorio Maranón, Madrid, Spain.

² Department of Pediatrics, Hospital Universitario Torrejón de Ardoz, Madrid, Spain.

³ Pediatric Infectious Disease, Department of Pediatrics, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

⁴ Department of Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

⁵ Pharmacy Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

⁶ Universidad Complutense Madrid. UCM. Spain.

⁷ Instituto Investigación Biomedica Gregorio Marañón IiSGM.

⁸ Instituto Nacional de Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, España.

Eduardo Jesús Bardón-Cancho.

None of the authors of this article have conflicts of interest to clarify. They have no commercial interests or other associations that could pose a conflict of interest.

Text word count: 3190

Abstract word count: 199

Brief running title: Antifungal prophilaxis with micafungin after bone marrow transplantation.

Key words: Antifungal prophylaxis, BMT for sickle cell disease, micafungin, children.

Tables: 2

Figures: 1